Q1 Results The Retin a micro no prescription company reported total revenues for the first quarter of 2001 of $971,000, compared with $730,000 for the same period in the prior year. An additional benefit of RETIN-A MICRO is that it can be applied immediately after patients wash their face, unlike RETIN-A, which requires a 20-30 minute waiting period. Designed to minimize the irritation commonly experienced with the highest strength of RETIN-A, RETIN-A MICRO entraps tretinoin in Microsponge(R) systems (round retin a micro no prescription microscopic particles made of synthetic polymer) and formulates them into a gel. Other risks and uncertainties associated with the company's business and prospects are identified in the company's filings with the Securities and Exchange Commission. Study participants also reported a statistically significant decrease in facial shine retin a micro no prescription on the RETIN-A MICRO side at the three- and six-hour interval. For further information Retin a micro no prescription visit the company's Website at www. Advancedpolymer.
RETIN-A(R) MICRO(TM) and RETIN-A(R) are marketed by Ortho Dermatological. The Company's primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer(TM). (Nasdaq:APPA), a specialty pharmaceutical company, today announced that Canadian drug regulatory authorities have granted marketing clearance for Retin-A Micro(R) (tretinoin gel) microsphere, 0.
Retin a micro no prescription 1% for the treatment of acne. Patients may see therapeutic results in two to seven weeks of treatment with RETIN-A MICRO. For further information visit the company's Web site at Retin a micro no prescription www. Appharma.
Initial targeted areas of application for retin a micro no prescription the company's drug delivery technology include pain management, inflammation, oncology, and ophthalmic and orthopedic applications. The net loss from continuing operations for the first quarter of 2001 was $963,000, compared with a net loss Retin a micro no prescription from continuing operations of $807,000 for the first quarter of 2000. RETIN-A MICRO contains tretinoin, the same active ingredient in RETIN-A and RENOVA(R) (tretinoin cream) 0. The retin a micro no prescription increase in revenues was primarily attributable to the commencement of royalties on sales of Carac, a newly approved topical treatment for pre-cancerous skin lesions, by the company's marketing partner Dermik Laboratories, an Aventis company. It is licensed to A.Highlights of the 2001 first quarter included: Michael O'Connell, president and CEO, commented, We have refocused Advanced Polymer Systems as a specialty pharmaceutical company, devoting our resources to the development of ethical pharmaceutical products with longer retin a micro no prescription life cycles and higher margins.